CDH1 and adenoma: In the present study, the modulators of the poor response to SA treatment were explored through a microarray analysis of adenomas with different expression levels of E-cadherin, as a marker of EMT progression, to identify transcripts that were differentially expressed after SA treatment of tumors and that were associated with E-cadherin mRNA expression.